Neurology Fellowships & Advanced Training Programs

Woman sits at computer to monitor sleep movement disorder patients

Next Steps with Neurology

The U-M Medical School Department of Neurology offers several fellowship opportunities as well as advanced training programs to continue your education and begin your career in academic medicine.

ACGME FELLOWSHIPS

The U-M Medical School Department of Neurology offers five ACGME board-certified fellowship programs. Click on the links below to learn more about each of our fellowships.

Epilepsy | Clinical Neurophysiology

Epilepsy fellowship and Clinical Neurophysiology fellowship are twelve-month ACGME accredited programs.

Neuromuscular

Neuromuscular Fellowship is a one-year, ACGME accredited program of advanced training in diagnosis, management and pathology of neuromuscular disorders.

Sleep Medicine

Sleep Medicine fellowship is an ACGME accredited program devoted to the development of fellows’ expertise in the diagnosis and management of sleep-wake disorders.

Vascular Neurology | Stroke

Our goal is to attract highly qualified and motivated candidates interested in pursuing a career in clinical, health service, or basic science stroke research.

Advanced Training Programs

The U-M Medical School Department of Neurology offers five non-ACGME accredited advance training programs. Follow the links below to learn more about each of our programs.

Cognitive Neurology & Neurodegenerative Disease

Train at the intersection of cognitive/behavioral neurology, neurodegenerative disease and clinical/translational research during the two-year program.

Headache Medicine

The Headache Medicine Advanced Training Program is a one-year program accredited by UCNS, focusing on diagnosing and treating head and face pain.

Movement Disorders

We are proud to offer a two year, comprehensive movement disorders training program that draws from a wealth of clinical, research and educational opportunities made available here at the university.

Multiple Sclerosis & Clinical Neuroimmunology

The program focuses on the diagnosis and longitudinal management of multiple sclerosis and related inflammatory disorders of the central nervous system.

Neuro-Oncology

The Neuro-Oncology program provides training for neurology residents or internal medicine candidates with oncology fellowship training aiming for a career in academic or clinical neuro-oncology.

Sports Neurology

The goal of the training is to provide an environment for acquiring the knowledge, skills and clinical judgment essential to the practice of Sports Neurology.

Zoomed in view of scientist looking through microscope

See Where Training Takes Place

We have a long tradition of providing world-class training in clinical neurology. Your experience at the University of Michigan Department of Neurology will afford you many opportunities and prepare you to be an educator and a leader in our health care community.

  • See Training Locations
    • Nightlife downtown Ann Arbor

    Life in Ann Arbor

    We find a new reason to love Ann Arbor nearly every day — year-round outdoor activities, cultural experiences, a growing food scene, and a welcoming, family-friendly atmosphere are just a few that come to mind. Explore all that Ann Arbor and our surrounding communities have to offer. 

  • Explore Ann Arbor

    • FEATURED NEWS & STORIES
    prescription pad drawn
    Health Lab

    Who gets Alzheimer’s drugs? Race, vulnerability and health status shape access

    A Michigan Medicine study found major disparities in access to new Alzheimer’s drugs, with Black and Hispanic patients less likely to receive treatment, though adherence was similar once therapy began.
    Department News

    Who gets Alzheimer's drugs? Race, vulnerability and health status shape access

    The findings, published in Neurology, highlight potential disparities in access to a new class of Alzheimer's treatments as use of these therapies increases.
    Department News

    Where Sleep Medicine Is Heading After SLEEP 2026: Anita Shelgikar, MD, MHPE

    Dr. Shelgikar, professor of neurology at the University of Michigan Medical School discussed the themes that defined SLEEP 2026, and what they signal for clinical practice heading into 2027
         Minding memory above a microphone on a blue background
    Minding Memory

    Can Your Voice Reveal Early Signs of Alzheimer’s?

    In this episode, Lauren & Matt speak with Neguine Rezaii, MD, an Assistant Professor of Neurology at Harvard Medical School and a Board-Certified Neuropsychiatrist at Mass General Hospital. Dr. Rezaii’s research focuses on using natural language processing and artificial intelligence to improve the detection and classification of neurodegenerative disorders. Dr. Rezaii talks about her recent study, “Voiceprints of Cognitive Impairment: Analyzing Digital Voice for Early Detection of Alzheimer’s and Related Dementias,” which explores how artificial intelligence can analyze short speech samples to identify subtle signs of cognitive impairment. The study used speech recordings from 120 individuals and found that features such as pauses, word choice and the specificity of language can help distinguish cognitive impairment and Alzheimer’s disease. The conversation also explores how a simple 30-second speech test could potentially be used in clinical settings to support earlier detection and monitoring of cognitive impairment, as well as the challenges and ethical considerations that come with using AI to analyze something as personal as a person’s voice.
         Cole, wearing sunglasses and a purple Calming the Storm t-shirt with a rainbow, is seated on a blanket outdoors and holding a Mott teddy bear.
    Philanthropy News

    A pediatric epilepsy fundraiser that changes lives

    Your support of Calming the Storm advances pediatric epilepsy research and patient care programs. There are many ways you can contribute to make a difference for so many children and families.
    Department News

    New blood tests offer another tool to detect Alzheimer’s early

    Alzheimer's disease can be hard to pin down early-on. But a new generation of blood tests is giving doctors another way to look for it.